documents: FDA-2010-P-0624-0007
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2010-P-0624-0007 | FDA | FDA-2010-P-0624 | Exhibit 25 - "FDA/CDER Letter to Cubist Pharmaceuticals, Inc., March 22, 2004" - [Cubist Pharmaceuticals, Inc. - Supplement] re FDA-2010-P-0624-0005 | Supporting & Related Material | SUP-Supplement (Supporting and Related Material) | 2011-02-15T05:00:00Z | 2011 | 2 | 2011-02-16T00:26:38Z | 0 | 0 | 0900006480bcd3d0 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref